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Condensed Abstract: More than half of participants reported problems with sexual functioning 
at each assessment and increased probabilities of reporting sexual dysfunction were observed 
over time and for YA cancer patients who were female, in a relationship, treated with 
chemotherapy, and reporting comorbid psychological distress and lower social support. For 
women, being in a relationship increased the likelihood of reporting sexual problems over time; 
for men reporting sexual problems over time increased regardless of relationship status.  
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Abstract 
Background 
Cancer-related sexual dysfunction has been reported among adolescents and young adults; 
however its prevalence over time has not. This longitudinal study investigated sexual 
dysfunction in AYAs over two years following initial diagnosis. 
Methods 
Young adult (YA) patients (18-39 years) completed the MOS Sexual Functioning Scale within 
the first 4 months of diagnosis (n=123), and again 6 (n=107) and 24 months later (n=95). An 
ordered multinomial response model analyzed changes in the probability of reporting sexual 
dysfunction over time and the independent effects of demographic, clinical, and psychosocial 
variables. 
Results 
More than half of participants experienced sexual functioning to be problematic at each 
assessment. The probability of reporting sexual dysfunction increased over time (<.01) and was 
greater for cancer patients who were female (<.001), older (<.01), married or in a committed 
relationship (<.001), treated with chemotherapy (<.05), and reporting comorbid psychological 
distress (<.001) and lower social support (<.05). For women, being in a relationship increased 
the likelihood of reporting sexual problems over time; for men reporting sexual problems over 
time increased regardless of relationship status. 
Conclusions 
A substantial proportion of YAs report on-going problems with sexual functioning in the first 
two years following their cancer diagnosis. These findings justify the need to evaluate and 
monitor sexual functioning throughout a continuum of care.  
 
Keywords: cancer, sexual functioning, AYA, adolescents, young adults 
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INTRODUCTION 
Adolescents and young adults (AYAs) with cancer, as defined by the National Cancer 
Institute, are individuals between 15 and 39 years of age at diagnosis.1 Considerable research has 
unveiled unique challenges experienced by AYAs, including poor quality of life, altered body 
image, and social isolation.2-4 As a consequence of these life disruptions, normative 
psychological and emotional development is impacted by the disease and its treatment, 
particularly with regard to sexual identity, development, and behavior.5 However, few studies 
have examined sexual functioning and AYA patients’ needs with regard to emotional intimacy 
and sexual relationships.6-8 
Cancer symptoms and treatment-related physical difficulties affect a healthy sexual 
development among AYAs.6, 9. Nerve damage can cause erectile and ejaculatory dysfunction, 
reduce sexual desire, and impair the ability to reach orgasm in both men and women.10 Younger 
women may be particularly vulnerable to the physiological effects of chemotherapy, which often 
induces early menopause, vaginal dryness, and dyspareunia.11 Estimates of the prevalence of 
sexual dysfunction in AYAs are limited to date and vary due to data being derived from mixed-
age groups, single items instead of standardized instruments, and cross-sectional designs.7 Yet, 
the state of the science suggests that one-third to two-thirds of cancer patients experience sexual 
dissatisfaction and reduced frequency of intercourse.4, 6, 7 One prior study reported that at 1 and 2 
years post-diagnosis, prevalence of sexual problems for AYAs was 49% and 43% respectively.7 
Correlates of sexual problems include age, gender, relationship status, physical function, body 
image, and health-related quality of life.6, 7, 12 
Sexual dysfunction describes a disorder that affects one or more phases of the human 
sexual response cycle,13 potentially leading to psychological and relational distress.14 Integrative 
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models of sexuality that consider relational, psychological, cultural, and physiologic aspects have 
emerged in cancer survivorship and direct this work.10, 13 While prevalence rates of sexual 
problems have been reported for 30-50% of healthy adults15 and 44-57% of healthy 
adolescents,16, 17 recent research suggests that the implications of sexual dysfunction for young 
people diagnosed with cancer in their teenage and young adult years are different from those of 
healthy peers, childhood cancer survivors, and adult cancer patients. AYAs are more likely to 
enter committed partnerships and to start a family while facing cancer.6, 7 Furthermore, failure to 
address sexual health may place AYAs at risk for long term consequences related to sexual 
functioning and identity development,18 interpersonal relationships,4 and quality of life.19 As 
such, detecting changes in the rate of sexual dysfunction over time may help in identifying 
appropriate timing for interventions to be delivered. The present work extends current 
knowledge of sexual functioning among AYAs by examining the prevalence of sexual 
dysfunction over two years following initial cancer diagnosis. It also aims to identify variables 
that contribute to sexual dysfunction in order to recognize individuals at higher risk. 
MATERIALS AND METHODS 
This study is part of a larger multisite longitudinal investigation of psychosocial outcomes 
in a national sample of AYAs, with study details reported elsewhere.20 Institutional Review 
Board approval was obtained at the coordinating center and from each participating site.  
Sample and Procedure 
Serial recruitment over two years (2008-2010) involved identifying young people treated at 
three children’s hospitals and two university-affiliated adult medical institutions in California, 
Oregon, and Texas, age 14-39 years, first diagnosis with any invasive cancer, and able to read 
and understand English or Spanish. Data were collected within 4 months from diagnosis, and 
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again 6 and 24 months later. Young adult (YA) patients (≥ 18.y.o.) were administered the sexual 
functioning scale as part of the survey, and only those who completed the instrument at least 
once were included in this analysis. Hence, 123 participants comprised the baseline sample. Five 
participants died between the first and the second assessment, and complete data were available 
for 107 patients at the 6 month follow-up (13% attrition rate). When the survey was administered 
again 2 years after baseline, 12 patients were deceased and 95 returned the materials (22.7% 
attrition rate).  
Measures 
Sexual Functioning was measured with the MOS Sexual Functioning Scale,21 a validated 
instrument used to identify sexual impairment accompanying serious health conditions. Four 
items assess the individual’s ability to be interested in sex and to achieve sexual arousal and 
orgasm. The scale is sensitive to gender differences, with two separate versions for males and 
females. Items are measured on a Likert scale ranging from 1 = “not a problem” to 4= “very 
much a problem.” A fifth response category (“not applicable”) indicates that the respondent is 
not sexually active, and is recorded as “not a problem” according to manualized scoring 
instructions.22 The total score is obtained for males and females by averaging the sum of the 
items and then transforming the scores on a 0-100 scale, with higher scores indicating more 
impairment. Cronbach’s alpha was .90 and .92 for men and women.21 
Psychological Distress. The Brief Symptom Inventory-18 (BSI-18) is a well-established 
instrument to screen for psychological distress.23, 24 It contains 18 items organized into three 
subscales (depression, somatization, anxiety) and a summarized Global Symptom Index (GSI). A 
five-point Likert scale (ranging from 0=‘not at all’ to 4=‘extreme’) measures the extent to which 
a respondent has experienced distress over the past week. Raw scores are converted to age- and 
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gender-adjusted T-scores for comparison to community norms (mean=50, SD=10), with higher 
scores indicating greater distress. A GSI score ≥ 63 suggests clinical distress and need for 
assessment. Cronbach’s alpha was .95 in the original study.23 
Health-Related Quality of Life. The Short Form 36 (SF-36) assesses health-related quality 
of life.25 The instrument includes eight subscales: physical functioning, physical and emotional 
role limitations, bodily pain, social functioning, mental health, vitality, and general health 
perceptions. Subscale scores are standardized and then aggregated in a Physical and a Mental 
Component Score, with higher scores indicative of better functioning. Data for summary scales 
are presented as T-scores (mean =50, SD=10). Cronbach’s alpha was .90.25  
Social Support. Social support was investigated with the MOS Social Support Survey.26 It 
is a questionnaire composed of 19 items that used 5 response categories. Scores are calculated 
for five functional support scales and an overall social support index, with higher scores 
indicating greater social support. Only the total score was included in the analysis. Cronbach’s 
alpha of the original scale was higher than .90.26  
Demographic and clinical characteristics. Demographic measures, including gender, race, 
education, income, employment, and relationship status were self-reported. Clinical data 
obtained from medical records comprised of age at diagnosis, cancer types and treatment. Three 
categories of severity were created from Surveillance Epidemiology and End Results (SEER) 
codes: (1) diseases with expected five-year survival rates greater than 80%; (2) diseases with 
expected five-year survival rates between 50-80%; and (3) all other invasive malignancies with 
expected five-year survival rates less than 50%. 
Data analysis 
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Descriptive statistics summarized the sample at each time point. Then, single item 
frequencies for sexual functioning by gender were computed (see Additional Materials). Due to 
the non normal distribution of the mean score of the outcome variable, a nonlinear analysis using 
an ordered multinomial response model with a log-link function was implemented to analyze 
changes in the probability of reporting sexual dysfunction over time, treating the outcome 
variable as ordinal. Respondents with a total sexual function score ≤ 25 were assigned “not a 
problem,” those with scores ranging from 26-50 were assigned “a little of a problem,” those with 
score ranging from 51-75 were assigned “somewhat of a problem,” and those with scores ≥76 
were assigned “very much of a problem.” Hierarchical generalized linear modeling (HGLM) 
with backward selection method allowed to identify patterns within (level 1) and between (level 
2) individuals, as well as for testing potential interactions.27 Model fit was accomplished with 
Bayesian modeling using Markov Chain Monte Carlo (MCMC) estimation,28 with MLwiN, 
version 2.24.29 Continuous variables were grand mean-centered, to control for potentially 
problematic correlations among random components30. The model was allowed to vary on the 
intercept (level 2). The distribution of each variable, including outliers, was inspected and 
corrected to prevent any violation of functional form. No missing data existed for the second and 
third survey time point on the outcome measure. 
At level 1, the outcome variable differs over time within individuals and it is a function of 
time and individual-specific change parameters. At level 2, individual-specific change 
parameters are considered to vary between subjects and are modeled as a function of variables 
differing between individuals. Time variant variables within patients (level 1) included 
relationship status, employment, treatment type, psychological distress, summary measures of 
physical and mental health, and social support. Time invariant variables (level 2) included sex, 
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race, education, age at diagnosis, and severity of disease. Model-fit was accomplished by first 
estimating the unconditional means model (Model A) that simply described and partitioned the 
outcome variation. Time was then added to estimate the unconditional growth model (Model B), 
where change in the outcome variable was described over time. Then the conditional growth 
model with time invariant and time variant main effects was estimated (Model C), and finally the 
conditional growth model with main and interaction effects (Model D).  
RESULTS 
Demographic, clinical, and psychological measures are summarized in Table 1. Participants 
were mostly men (53.7%), Non-Hispanic white (53.3%), diagnosed with cancer in their late 20s 
(mean 28.2), and had received treatment including chemotherapy (72.1%). At baseline most 
AYAs were involved in a romantic relationship (58.7%). At the 6 months follow-up the 
proportion declined to 40% and at 2 years post-diagnosis 43.2% of participants were partnered. 
Psychological distress increased over time, with the mean GSI score ranging from 57.1 at 
baseline to 68.3 at the last follow-up. Both physical and mental components of health-related 
quality of life improved over time; however they remained below the standardized population 
mean. Rates of social support remained elevated over time.  
At baseline and six month follow-up, more than half of all YA patients (52% and 54.2% 
respectively) reported some degree of problem with sexual functioning. After 2 years more than 
half (52.1%) of the sample still reported some degree of affected sexual functioning (Table 2). 
Results of the ordered multinomial response model (Table 3) indicate that increased probabilities 
of sexual dysfunction were reported over time (p<.01). In this sample, a significant main effect 
of gender was detected, with women presenting higher likelihood of reporting sexual problems 
than men (p<.001). Worse sexual functioning was predicted for older cancer patients (p<.01), 
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with young adults at the 90th percentile of age (approximately 38 years) more likely to report 
sexual dysfunction than younger participants (10th percentile, 19 years). Additionally, YAs who 
were involved in a relationship with a partner were estimated to have higher probabilities of 
experiencing sexual dysfunction (p<.001). Among clinical factors, cancer patients who received 
chemotherapy had an increased chance of sexual problems (p<.05). Higher psychological 
distress was significantly associated with increased probabilities of sexual dysfunction (p<.001). 
On the contrary, social support was predictive of reduced likelihood of sexual problems (p<.05). 
Finally, two significant interactions were identified: a two-way interaction of cancer survival by 
gender (p<.01), and a three-way interaction of time by gender and relationship status (p<.05). 
While among women with higher survival rates the probabilities of reporting sexual functioning 
as problematic were similar, worse sexual outcomes were predicted for those with a survival rate 
less than 50% (Figure 1). For males probabilities were similar across the three groups. Figure 2 
presents the predicted probabilities of sexual dysfunction over time for the two genders by 
relationship status. For women, being in a relationship increased the likelihood of reporting 
sexual problems over time than not-partnered females; for men reporting sexual problems over 
time increas d regardless of relationship status. 
DISCUSSION 
Following earlier research indicating that 43% of patients reported affected sexual life 2 
years post-diagnosis,7 the current study provides further evidence that substantial portions of 
YAs continue to struggle with sexual functioning over time. Rates of sexual dysfunction 
observed here are consistent with those found in other studies. Among male survivors of 
lymphoma, sexual dysfunction ranged from 20% to 54% across studies31, while for testicular 
cancer patients the percentages varied from 11% for loss of desire to 51% for ejaculation 
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problems.32 Up to 52% of young breast cancer patients were found to experience sexual 
problems33 and to present poorer sexual function compared to both older survivors and age-
matched control groups.34 In a cross-sectional study of sexual satisfaction and quality of close 
relationships among young German patients, one-third of the sample was not satisfied with 
sexual life and frequency of intercourse.6 However, our participants reported higher prevalence 
than those in the work by Wettergren et al.;7 a result which may be partially explained by the 
different measures (dichotomous item vs. questionnaire). The MOS Sexual Functioning scale has 
been previously used in cross-sectional studies to assess sexual problems in childhood cancer 
survivors35 and validated with adults faced with medical conditions.22 Our participants reported 
greater prevalence of sexual dysfunction than childhood cancer survivors (42.7%), however in 
the validation study of the scale 59% of the sample reported sexual problems21. Despite these 
differences, our results confirm that sexual functioning of young adults is significantly affected 
by cancer, with implications for the well-being of the individual that extend beyond active 
treatment.  
Female gender was associated with higher probabilities of sexual dysfunction, especially 
for those with a survival rate less than 50%. Although a few studies have analyzed gender 
differences in the presentation of sexual dysfunction among AYAs, the worse outcomes 
observed for women are consistent with data from existing literature.8, 36-38 Notably, a study 
revealed that more than 70% of young female survivors experience reduced frequency of sexual 
intercourse after diagnosis.6 Our findings are also similar to the work of Champion et al.,34 who 
identified a pattern of decreased interest, arousal, and frequency of orgasm. Sexual difficulties in 
young women begin after surgery, and although for some they gradually decrease, sexual 
functioning remains problematic one39 and five years40 later. 
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The probability of sexual problems increased over time for all YAs; however when 
accounting for relationship status sexual problems worsened for women who were married or in 
a relationship, whereas for men sexual dysfunction worsened regardless of their relationship 
status, suggesting that sexual functioning is experienced differently by gender. While results 
confirm that sexual problems are reported by cancer patients involved in a relationship,12, 35 the 
diverging trends for women and men not in a relationship direct the attention toward male 
patients, as this group may be at higher risk for long-term sexual problems. Our finding reflects 
the complexity of adjusting and coping with cancer as a young adult and recommend additional 
research to examine the differential effects of cancer on sex and sexuality for men, women, and 
transgender young people. 
Older age, chemotherapy, and psychological distress were predictive of the probability of 
reporting sexual dysfunction while social support had a protective effect in this sample. Worse 
outcomes for young adults confirm the more detrimental effect of cancer on their sexual 
functioning.7 Similarly, previous linkage of chemotherapy with sexual dysfunction,41 either 
directly or because of treatment- related consequences, was confirmed.42 Future research is 
needed to determine the extent to which biological, neurological, and psychological mechanisms 
interact in this population. YAs reporting high psychological distress had greater probabilities of 
worse sexual functioning12, 43, 44 but no significant role was played by health-related quality of 
life; a lack of significance similar to results from the AYA HOPE study.7 Finally, the relevance 
of supportive networks for this group9 is represented by the result for perceived social support. 
Some limitations affect the current study. First, more frequent assessments would have 
provided more accurate estimates of sexual dysfunction. Second, the MOS Sexual Functioning 
Scale focuses on performance indicators but excludes satisfaction with sexuality and associated 
Page 12 of 27Cancer
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
13 
 
distress. Since addressing sexual problems in the context of cancer requires an integrative 
approach,10 a multi-dimensional measure should have been considered. Attrition rates confirm 
the challenges of recruiting and following-up with AYAs.45 Studies that actively promote subject 
retention are needed. Finally, the study did not include a matched-control group, and therefore 
lacks the ability to compare current findings with normative data. 
Approximately half of YA cancer patients experienced some degree of sexual dysfunction 
for up to two years post-diagnosis, which reached moderate-to-severe levels for nearly one-
quarter of the sample. Time, demographic, clinical, and psychosocial variables contributed to 
reporting sexual problems. Embarrassment and limited training among providers have 
contributed to the current lack of attention for sexual dysfunction among AYAs.46 This study 
emphasizes the need to implement protocols that monitor sexual functioning throughout a 
continuum of care and connect patients to psychosocial interventions that alleviate the life 
disruptions caused by cancer and its treatment.   
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Table 1. Sample demographic, clinical, and psychosocial characteristics  
 
 
Characteristics 
 N (%)  
Baseline  
 
(N=123) 
6 months  
Follow-Up 
(N=107) 
24 months 
Follow-Up 
(N=95) 
Demographic Characteristics    
Gender* 
Male 
Female 
 
66(53.7%) 
57(46.3%) 
  
Relationship Status 
Yes 
No 
 
71(58.7%) 
50(41.3%) 
 
42(40.0%) 
63(60.0%) 
 
41(43.2%) 
50(52.6%) 
Race* 
Non-Hispanic White 
Hispanic/Latino 
Others 
 
65(53.3%) 
43(35.2%) 
14(11.5%) 
  
Education* 
High School or less 
Some college or more 
 
46(37.7%) 
77(62.3%) 
  
Income* 
Under $25,000 
Above $25,001 
 
58(47.9%) 
63(52.1%) 
  
Employment/School status 
Not Occupied 
Occupied 
 
71(59.7%) 
48(40.3%) 
 
53(51.0%) 
51(49.0%) 
 
37(39.8%) 
56(60.2%) 
Clinical Factors    
Age at Diagnosis, Mean (SD) 28.2(7.1)   
Age at Diagnosis (Categorical) 
18-25 years 
26-39 years 
 
43(35.0%) 
80(65.0%) 
  
Type of Cancer (% of survival)* 
< 50%  
50-80%  
80-100%  
 
32(26.0%) 
49(39.8%) 
42(34.1%) 
  
Cancer Type* 
Leukemia 
Breast  
Soft Tissue Sarcoma 
NHL 
Bone  
Testicular  
Hodgkin’s Disease 
Female Genital  
Brain 
Other  
 
19(15.6%) 
18(14.8%) 
15(12.3%) 
13(10.7%) 
10(8.2%) 
10(8.2%) 
9(7.4%) 
7(5.7%) 
6(4.9%) 
15(12.2%) 
  
Treatment 
Chemotherapy 
Radiation 
Surgery 
 
88(72.1%) 
23(18.9%) 
30(24.6%) 
 
42(39.3%) 
3(2.8%) 
12(14.0%) 
 
24(25.5%) 
− 
22(23.4%) 
Psychosocial Variables    
Psychological Distress 
GSI Mean (SD) 
Range 
 
57.1(10.8) 
33.0-81.0 
 
55.1 (11.2) 
33.0-81.0 
 
68.3(5.8) 
61.0-81.0 
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Quality of Life  
SF36 Physical Component 
Mean (SD) 
Range 
SF36 Mental Component  
Mean (SD) 
Range 
 
39.9(10.4) 
 
13.7-59.6 
40.8(13.6) 
 
8.0-67.2 
 
39.6(10.5) 
 
13.8-62.0 
43.0(13.0) 
 
9.9-67.2 
 
40.1(10.1) 
 
13.7-61.9 
44.2(11.1) 
 
18.2-63.8 
Social Support  
MOS Social Support Overall Index 
(mean score) 
Range  
 
4.2( .9) 
 
1.0-5.0 
 
4.2( .9) 
 
1.0-5.0 
 
4.0(1.2) 
 
1.0-5.0 
* Variable measured only at baseline 
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Table 2. Sexual functioning groups obtained from the total scores on the MOS Sexual 
Functioning Scale  
 
  N (%)  
 Baseline 
 
(n=123) 
 
6 Months 
Follow-Up 
(n=107) 
 
24 Months 
Follow-Up 
(n=95) 
 
Sexual Functioning Not a Problem  59(48.0%) 49(45.8%) 45(47.9%) 
Sexual Functioning a Little of a Problem  31(25.2%) 26(24.3%) 17(17.9%) 
Sexual Functioning Somewhat of a Problem  14(11.4%) 21(19.6%) 14(14.7%) 
Sexual Functioning Very Much of a Problem  19(15.4%) 11(10.3%) 19(20.0%) 
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Table 3. Multilevel models predicting the probability of reporting sexual dysfunction over time (n=325) 
 
Parameters MODEL A MODEL B 
 
MODEL C 
 
MODEL D 
Fixed Part 
Constant(β0.012 jk) 
<=Sexual Functioning Not a Problem 
<=Sexual Functioning A Little of a Problem 
<=Sexual Functioning Somewhat of a Problem 
 
Time (β1.012jk) 
Female (β2 012 jk) 
Age (β3. 012 jk) 
Not in a Relationship (β4. 012jk) 
Chemotherapy(β5.012jk) 
Global Symptom Index (β6.012jk) 
Social Support (β7.012jk) 
Survival 50-80% (β8.012jk) 
Survival 80-100%(β9.012jk) 
Female*Survival 50-80% (β10. 012jk) 
Female*Survival 80-100% (β11. 012jk) 
Time*Female*Not in a Relationship (β12. 012jk) 
 
 
-0.09(0.2) 
1.32(0.2)*** 
2.59(0.3)*** 
 
 
0.21(0.4) 
1.66(0.4)*** 
2.95(0.5)*** 
 
-0.16(0.1) 
 
 
0.21(0.6) 
1.80(0.6)** 
3.23(0.7)*** 
 
-0.42(0.2)* 
-0.33(0.4) 
-0.08(0.1)** 
1.15(0.3)*** 
-0.67(0.3)* 
-0.06(0.1)*** 
0.42(0.2)* 
0.60(0.5) 
0.53(0.5) 
 
 
1.44(0.7)* 
3.04(0.7)*** 
4.49(0.8)*** 
 
-0.50(0.2)** 
-2.51(0.7)*** 
-0.07(0.1)** 
0.68(0.4) 
-0.73(0.3)* 
-0.06(0.1)*** 
0.37(0.2)* 
-0.60(0.6) 
-0.63(0.6) 
2.36(0.8)** 
2.44(0.9)** 
0.48(0.2)* 
Variance Components     
Level 1- Within Person     
constant/constant (σ2v0) 2.7(0.8) 2.9(0.9) 2.4(0.9) 2.1(0.8) 
time/constant (σv01)     
time/time (σ2v1)     
Level 2 –Between Persons 
constant/constant (σ
2
v012) 
-2*LogLikelihood 
DIC 
pD 
Units: Case_ID 
Units: Level1ID 
Units: Resp Indicator 
 
 
 
757.9 
89.9 
154 
325 
975 
 
 
 
757.9 
93.5 
154 
325 
975 
 
 
 
721.3 
86.3 
154 
325 
975 
 
 
 
717.9 
82.1 
154 
325 
975 
*p < .05 **p < .01 *** p < .001 
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Figure Legends: 
Figure 1. Predicted probabilities of reporting sexual dysfunction by survival for the two 
genders 
 
Figure 2. Predicted probabilities of reporting sexual dysfunction by gender and relationship 
status  
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Figure 1. Predicted probabilities of reporting sexual dysfunction by survival for the two genders  
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Figure 2. Predicted probabilities of reporting sexual dysfunction by gender and relationship status  
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Table S1. Descriptive statistics for MOS Sexual Functioning Scale by gender 
 
  N (%)  
 Baseline 
 
(N=123) 
6 Months  
Follow-Up 
(N=107) 
24 Months 
Follow-Up 
 (N=95) 
Item 1-Lack of Sexual Interest     
Men    
Not a problem 44(66.7%) 42(73.7%) 32(62.7%) 
A little of a Problem  8(12.1%) 5(8.8%) 11(21.6%) 
Somewhat of a Problem  10(15.2%) 7(12.3%) 5(9.8%) 
Very Much of a Problem 4(6.1%) 3(5.3%) 3(5.9%) 
Women    
Not a problem 28(49.1%) 26(52%) 21(47.7%) 
A little of a Problem  11(19.3%) 9(18.0%) 9(20.5%) 
Somewhat of a Problem  5(8.8%) 7(4.5%) 5(11.4%) 
Very Much of a Problem 13(22.9%) 8(16.0%) 9(20.5%) 
Item 2-Unable to Relax and Enjoy Sex     
Men    
Not a problem 40(60.6%) 40(70.2%) 31(60.8%) 
A little of a Problem  9(13.6%) 7(12.3%) 7(13.7%) 
Somewhat of a Problem  11(16.7%) 6(10.5%) 10(19.6%) 
Very Much of a Problem 6(9.1%) 4(7.0%) 3(5.9%) 
Women    
Not a problem 35(61.4%) 28(56.0%) 25(56.8%) 
A little of a Problem  9(15.8%) 10(20.0%) 6(13.6%) 
Somewhat of a Problem  5(8.8%) 7(14.0%) 5(11.4%) 
Very Much of a Problem 8(14.0%) 5(10%) 8(18.2%) 
Item 3-Difficulty in becoming Sexually 
Aroused 
   
Men    
Not a problem 49(74.2%) 39(68.4%) 36(70.6%) 
A little of a Problem  8(12.1%) 11(19.3%) 6(11.8%) 
Somewhat of a Problem  5(7.6%) 4(7.0%) 5(9.8%) 
Very Much of a Problem 4(6.1%) 3(5.3%) 4(7.8%) 
Women    
Not a problem 38(66.7%) 28(56.0%) 22(50.0%) 
A little of a Problem  6(10.5%) 9(18.0%) 8(18.2%) 
Somewhat of a Problem  4(7.0%) 8(16.0%) 6(13.6%) 
Very Much of a Problem 9(15.8%) 5(10.0%) 8(18.2%) 
Item 4-Difficulty in getting or keeping an 
erection (Men); Difficulty having an 
orgasm (Women) 
   
Men    
Not a problem 49(74.2%) 40(70.2%) 36(70.6%) 
A little of a Problem  8(12.1%) 9(15.8%) 7(13.7%) 
Somewhat of a Problem  7(10.6%) 4(7.0%) 2(3.9%) 
Very Much of a Problem 2(3.0%) 4(7.0%) 6(11.8%) 
Women    
Not a problem 37(64.0%) 29(58.0%) 23(52.3%) 
A little of a Problem  10(17.5%) 11(22.0%) 9(20.5%) 
Somewhat of a Problem  3(5.3%) 5(10.0%) 7(15.9%) 
Very Much of a Problem 7(12.3%) 5(10.0%) 5(11.4%) 
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